Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fesco air delivery service transported 4 times more groupage cargoes

1/9/24 FESH

PIK lost its leadership in terms of current construction volumes

1/9/24 PIKK

Samolet' has become the new leader of the construction market

1/9/24 SMLT

NLMK shareholders appointed Sergey Karatayev as President of the Company

1/9/24 NLMK

Shareholders of Donskoy Factory of Radiocomponents approved dividends

1/9/24 DZRD

Tinkoff Bank received a FPI license in India

1/9/24 T

TCS Group shareholders' meeting on redomiciliation postponed for a week

1/9/24 T

Developer Samolet has acquired the Galernaya Gavan project

1/8/24 SMLT

MS-21 and Superjet are planned to be united under a common brand

1/4/24 UNAC

Gazprom updated the record of daily gas supplies via Siberia Power

1/3/24 GAZP